Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Bj??rn Scheffler
Affiliation
German Cancer Research Center (DKFZ)
ORCID
Career Start Year
1992
Papers
84
H Index
31
Expertise
CM4AI Collaborator
Trey Ideker (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36054558
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.
Int J Cancer
2023
37627083
Telemedicine in Neuro-Oncology-An Evaluation of Remote Consultations during the COVID-19 Pandemic.
Cancers (Basel)
2023
37547266
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma.
Neurooncol Adv
2023
37418389
TERT expression is associated with metastasis from thin primaries, exhausted CD4+ T cells in melanoma and with DNA repair across cancer entities.
PLoS One
2023
37335907
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression.
Neuro Oncol
2023
37334753
Surface Chemistry and Specific Surface Area Rule the Efficiency of Gold Nanoparticle Sensitizers in Proton Therapy.
Chemistry
2023
37296942
Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on Prognosis.
Cancers (Basel)
2023
36239995
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.
Clin Cancer Res
2023
35953681
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma.
J Cancer Res Clin Oncol
2023
35326526
Machine Learning Applications for Differentiation of Glioma from Brain Metastasis-A Systematic Review.
Cancers (Basel)
2022
35831316
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.
Nat Commun
2022
36284931
First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed <i>MGMT</i> promoter methylated <i>IDH</i> wildtype glioblastoma.
Neurooncol Adv
2022
35013174
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression.
Nat Commun
2022
33389825
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trial.
J Appl Clin Med Phys
2021
33789203
Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.
Eur J Cancer
2021
33502678
Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography.
J Neurooncol
2021
33937037
Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma.
Front Oncol
2021
34359673
How about Levetiracetam in Glioblastoma? An Institutional Experience and Meta-Analysis.
Cancers (Basel)
2021
34162860
Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression.
Nat Commun
2021
32307022
Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial.
Radiat Oncol
2020
33506201
Preoperative and early postoperative seizures in patients with glioblastoma-two sides of the same coin?
Neurooncol Adv
2020
32033141
Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer.
Cancers (Basel)
2020
31831598
Olfactory function as an independent prognostic factor in glioblastoma.
Neurology
2020
31828428
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma.
J Cancer Res Clin Oncol
2020
31743443
Exosome/microvesicle content is altered in leucine-rich repeat kinase 2 mutant induced pluripotent stem cell-derived neural cells.
J Comp Neurol
2020
33091717
Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastoma.
Eur J Cancer
2020
33003586
Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature.
Int J Mol Sci
2020
32711135
Challenging Implications of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids Syndrome with an Atypical Presentation: Report of Two Cases.
World Neurosurg
2020
32599645
Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma.
Int J Cancer
2020
30516675
Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016.
Clin Nucl Med
2019
31646997
Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case report.
BMC Cancer
2019
31586101
3D extracellular matrix microenvironment in bioengineered tissue models of primary pediatric and adult brain tumors.
Nat Commun
2019
30985412
Comparison of L-Methyl-11C-Methionine PET With Magnetic Resonance Spectroscopy in Detecting Newly Diagnosed Glioma.
Clin Nucl Med
2019
30894200
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
J Transl Med
2019
30820715
Regorafenib in patients with recurrent high-grade astrocytoma.
J Cancer Res Clin Oncol
2019
30721788
Sequence-dependent cross-resistance of combined radiotherapy plus BRAF<sup>V600E</sup> inhibition in melanoma.
Eur J Cancer
2019
29754968
Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma.
J Clin Neurosci
2018
27521447
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma.
Clin Cancer Res
2017
28030820
Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma.
Oncotarget
2017
27100354
Phase I trial of dovitinib (TKI258) in recurrent glioblastoma.
J Cancer Res Clin Oncol
2016
26673798
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.
Clin Cancer Res
2016
27591333
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases.
Neuro Oncol
2016
26827696
Therapy of leptomeningeal metastasis in solid tumors.
Cancer Treat Rev
2016
25328136
DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2.
Oncogene
2015
26103419
Evolutionary trends and functional anatomy of the human expanded autophagy network.
Autophagy
2015
24942787
Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma.
Oncology
2014
23460716
Vemurafenib for leptomeningeal melanomatosis.
J Clin Oncol
2013
24068827
Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment.
J Neurosci
2013
23908450
Anticancer effects of niclosamide in human glioblastoma.
Clin Cancer Res
2013
23963648
Tenascin-C is expressed by human glioma in vivo and shows a strong association with tumor blood vessels.
Cell Tissue Res
2013
1 - 50 of 84
Column Actions
Search
Recommended Authors
Briana C Prager
Massachusetts General Hospital
Career Start Year
2015
Number of shared co-authors
7
Kyounghee Seo
University of California san francisco
Career Start Year
2012
Number of shared co-authors
0
Roberto Fiorelli
Barrow Neurological Institute
Career Start Year
2008
Number of shared co-authors
0
Joanna J Phillips
University of California san francisco
Career Start Year
2006
Number of shared co-authors
13
Chitra Venugopal
McMaster Stem Cell and Cancer Research Institute
Career Start Year
2006
Number of shared co-authors
7
Nancy Ann Oberheim Bush
University of California san francisco
Career Start Year
2005
Number of shared co-authors
3
Adam M Sonabend
Northwestern University
Career Start Year
2005
Number of shared co-authors
0
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Career Start Year
2002
Number of shared co-authors
0
Marco Skardelly
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year
2002
Number of shared co-authors
0
Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Career Start Year
2002
Number of shared co-authors
4
Sheila K Singh
McMaster University
Career Start Year
2001
Number of shared co-authors
10
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year
2001
Number of shared co-authors
0
Jeongwu Lee
Lerner Research Institute, Cleveland Clinic
Career Start Year
2001
Number of shared co-authors
1
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year
1998
Number of shared co-authors
6
Anders I Persson
University of California san francisco
Career Start Year
1998
Number of shared co-authors
3
Ian D Clarke
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Career Start Year
1997
Number of shared co-authors
9
John A Boockvar
Lenox Hill Hospital
Career Start Year
1997
Number of shared co-authors
0
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Career Start Year
1996
Number of shared co-authors
5
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
2
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year
1996
Number of shared co-authors
10
Daniel A Lim
University of California san francisco
Career Start Year
1993
Number of shared co-authors
0
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year
1992
Number of shared co-authors
11
Howard A Fine
Meyer Cancer Center
Career Start Year
1990
Number of shared co-authors
2
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Career Start Year
1990
Number of shared co-authors
1
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year
1990
Number of shared co-authors
8
Angelo L Vescovi
IRCCS Casa Sollievo della Sofferenza, University of Milano-Bicocca
Career Start Year
1986
Number of shared co-authors
2
Peter B Dirks
The Hospital for Sick Children, University of Toronto
Career Start Year
1986
Number of shared co-authors
11
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Career Start Year
1984
Number of shared co-authors
2
Gaetano Finocchiaro
IRCCS San Raffaele Scientific Institute
Career Start Year
1983
Number of shared co-authors
10
Steven A Goldman
Center for Translational Neuromedicine, University of Rochester Medical Center
Career Start Year
1982
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Martin Glas
University Hospital Essen
Co-authored papers
46
Theophilos Tzaridis
Co-authored papers
6
Torsten Pietsch
Co-authored papers
6
Andreas Till
University Hospital Bonn
Co-authored papers
6
Dirk Schadendorf
Co-authored papers
3
Guido Reifenberger
Heinrich Heine University
Co-authored papers
3
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers
2
Holger Fr??hlich
Bonn-Aachen International Center for IT (B-IT), University of Bonn
Co-authored papers
2
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers
2
Martin Kolnik
Miltenyi Biotec Inc.
Co-authored papers
1
Julie Talbot
Institut Curie, Inserm, CNRS, Universite Paris-Saclay
Co-authored papers
1
Idriss Mahoungou Koumba
and Clinical Immunology, Heinrich Heine University
Co-authored papers
1
Grigori Enikolopov
Co-authored papers
1
Andreas Buness
Co-authored papers
1
Antoine Forget (CM4AI)
University of California San Francisco
Co-authored papers
1
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers
1
Flavia Bernardi
Institut Curie, PSL Research University, CNRS UMR, INSERM
Co-authored papers
1
Nan Qin
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers
1
Gerhard Steger
Institut fur Pysikalische Biologie, Heinrich Heine University Dusseldorf
Co-authored papers
1
Anja Stefanski
Universitatsklinikum
Co-authored papers
1
Jingjing Liu
College of Tropical Crops, Hainan University
Co-authored papers
1
David L Kaplan
Co-authored papers
1
Lena Bl??mel
German Cancer Research Center (DKFZ)
Co-authored papers
1
Anthony E Oro
Stanford University
Co-authored papers
1
Leonora Balaj
Massachusetts General Hospital
Co-authored papers
1
Robert J Wechsler-Reya
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
1
Soumav Nath
Institut fur Physikalische Biologie, Heinrich-Heine-Universitat Dusseldorf
Co-authored papers
1
Kotb Abdelmohsen
National Institute on Aging, National Institutes of Health
Co-authored papers
1
Thomas Gr??newald
Hospital Chemnitz
Co-authored papers
1
Frauke-Dorothee Meyer
German Cancer Research Center (DKFZ)
Co-authored papers
1
1 - 30